Targeting targeted therapies

Immunotherapy. 2010 Nov;2(6):745-8. doi: 10.2217/imt.10.66.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, Neoplasm / genetics
  • Antigens, Neoplasm / immunology*
  • Benzamides
  • Cancer Vaccines / genetics
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Imatinib Mesylate
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Piperazines / immunology
  • Piperazines / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / immunology
  • Pyrimidines / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Benzamides
  • Cancer Vaccines
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases